BeyondSpring (NASDAQ:BYSI) Trading Down 5.6%

BeyondSpring Inc. (NASDAQ:BYSI) fell 5.6% during mid-day trading on Friday . The company traded as low as $2.51 and last traded at $2.68. 41,960 shares were traded during trading, a decline of 74% from the average session volume of 159,423 shares. The stock had previously closed at $2.84.

BeyondSpring Stock Performance

The firm has a 50 day moving average price of $2.63 and a two-hundred day moving average price of $1.62.

Institutional Trading of BeyondSpring

Hedge funds have recently modified their holdings of the business. Capstone Capital Wealth Advisors purchased a new stake in shares of BeyondSpring during the fourth quarter worth $45,000. SG Americas Securities LLC purchased a new stake in shares of BeyondSpring during the first quarter worth $63,000. Decheng Capital Management III Cayman LLC purchased a new stake in shares of BeyondSpring during the third quarter worth $3,967,000. Finally, Decheng Capital LLC purchased a new stake in shares of BeyondSpring during the fourth quarter worth $4,450,000. Hedge funds and other institutional investors own 40.29% of the company’s stock.

About BeyondSpring

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.